Hoffmann, Elgin
Paulsen, Frank
Schaedle, Philipp
Zips, Daniel
Gani, Cihan
Rammensee, Hans-Georg
Gouttefangeas, Cécile
Eckert, Franziska http://orcid.org/0000-0002-4742-3962
Funding for this research was provided by:
Medizinischen Fakultät, Eberhard Karls Universität Tübingen (261-0-0, 444-0-0, 261-0-0, 2154-0-0, 2007-0-0)
Deutsche Forschungsgemeinschaft (EXC2180, EXC2180)
Deutschen Konsortium für Translationale Krebsforschung
Deutsche Krebshilfe (70114187)
Eberhard Karls Universität Tübingen
Article History
Received: 3 May 2021
Accepted: 28 June 2021
First Online: 16 July 2021
Declarations
:
: E. Hoffmann: Research and educational grants from Elekta, Philips, Siemens, and Sennewald. F. Paulsen: Research and educational grants from Elekta, Philips, Siemens, and Sennewald. P. Schaedle: No conflict of interest. D. Zips: Research and educational grants by Elekta, Philips, Siemens, Sennewald, Kaikuu, and TheraPanacea C. Gani: Research and educational grants, sponsoring for symposia by Elekta, Philips, Siemens, Sennewald, Kaikuu, and TheraPanacea. H.-G. Rammensee: No conflict of interest. C. Gouttefangeas: No conflict of interest. F. Eckert: Research and educational grants from Elekta, Philips, Siemens, and Sennewald. Speaker’s honoraria by Sennewald.
: The study was approved by the local ethics committee (project number 402/2010BO2). All patients had signed informed consent.